New York, NY, United States of America

Hong-fen Guo

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Sloan-Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong-fen Guo. Retrieved from https://idiyas.com/inventor/hong-fen-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 50.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 140(Granted Patents)


Company Filing History:


Years Active: 2002-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hong-fen Guo

Introduction

Hong-fen Guo is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer research through her innovative inventions. With a total of 4 patents, her work focuses on the development of single chain antibodies, which have important applications in targeted cancer therapies.

Latest Patents

One of her latest patents is a method for the preparation of single chain antibodies. This invention provides a method for identifying cells expressing a target single chain antibody (scFv) directed against a target antigen from a collection of cells that includes cells that do not express the target scFv. The method involves combining the collection of cells with an anti-idiotype directed to an antibody specific for the target antigen and detecting any interaction of the anti-idiotype with the cells. The occurrence of an interaction identifies the cell as one that expresses the target scFv. Additionally, this invention outlines a method for making a single chain antibody (scFv) directed against an antigen, wherein the selection of clones is based on their interaction with an appropriate anti-idiotype.

Another significant patent by Hong-fen Guo is related to methods of preparing and using single chain anti-tumor antibodies. Similar to her previous invention, this method also focuses on identifying cells expressing a target single chain antibody (scFv) and involves the same steps of combining cells with an anti-idiotype and detecting interactions. This invention further emphasizes the various uses of these methods in cancer treatment.

Career Highlights

Hong-fen Guo is affiliated with the Sloan Kettering Institute for Cancer Research, where she continues to advance her research and innovations. Her work has been instrumental in the development of new therapeutic strategies for cancer treatment.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Nai-Kong V Cheung and Steven M Larson. These collaborations have further enhanced her research and contributed to the advancement of cancer therapies.

Conclusion

Hong-fen Guo's innovative work in the field of single chain antibodies has the potential to significantly impact cancer treatment. Her contributions through her patents and research at the Sloan Kettering Institute for Cancer Research highlight her dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…